retatrutide side effects phase 2 trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished What are the side effects

GSSG can be used as substrate for enzymatically assaying glutathione reductase

Safety of pasteurised EFSA J 2021;19:e06780

With the extensive development and application of drug-loaded nanosystems, a large number of studies have confirmed that drug-loaded nanoparticles have the effect of synergizing and reducing toxicity in the treatment of tumors, and nanoparticle drug delivery systems have become an effective solution to various obstacles in the delivery of anti-cancer drugs, anti-cancer natural products, and anti-cancer genes (244)

These are the main differences between the different types of GLP-1 agonists: Semaglutide (Ozempic, Wegovy) Strong anti-inflammatory potential Powerful metabolic benefits and weight loss Longer duration, but higher risk of GI and vestibular side effects Only works on immune cells receptors( not on adipose tissue directly) Tirzepatide (Mounjaro, Zepbound) Works on both GLP-1 and GIP receptors (targeting adipose tissue receptors) Strong anti-inflammatory and insulin-sensitivity effects Significant weight loss Higher likelihood of GI issues in some women Liraglutide (Saxenda) Daily injection Lowest weight loss and inflammation benefits Often gentler on the gut Poorer response for Lipedema in later stages The best choice often depends on: Your gut health Whether you struggle with dizziness or vestibular issues Your appetite levels Your sensitivity to medications Your nutrition status For Lipedema patients, Tirzepatide remains the best therapeutic choice to have a significant benefit on the adipose tissue